|
KMID : 0620920230550081795
|
|
Experimental & Molecular Medicine
2023 Volume.55 No. 8 p.1795 ~ p.1805
|
|
|
The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis
|
|
Lee Soo-Yeon
Park Soo-Yeon
Lee Seung-Hyun
Kim Hyun-Sik
Kwon Jae-Hwan
Yoo Jung-Yoon
Kim Kyung-Gon
Phue Khaing
Lee Chun-Geun
Jack A. Elias
Sohn Myung-Hyun
Shim Hyo-Sup
Yoon Ho-Geun
|
|
|
Abstract
|
|
|
|
Idiopathic pulmonary fibrosis (IPF) is a chronic, fatal, fibrotic, interstitial lung disease of unknown cause. Despite extensive studies, the underlying mechanisms of IPF development remain unknown. Here, we found that p300 was upregulated in multiple epithelial cells in lung samples from patients with IPF and mouse models of lung fibrosis. Lung fibrosis was significantly diminished by the alveolar type II (ATII) cell?specific deletion of the p300 gene. Moreover, we found that ubiquitin C-terminal hydrolase L3 (UCHL3)-mediated deubiquitination of p300 led to the transcriptional activation of the chemokines Ccl2, Ccl7, and Ccl12 through the cooperative action of p300 and C/EBPβ, which consequently promoted M2 macrophage polarization. Selective blockade of p300 activity in ATII cells resulted in the reprogramming of M2 macrophages into antifibrotic macrophages. These findings demonstrate a pivotal role for p300 in the development of lung fibrosis and suggest that p300 could serve as a promising target for IPF treatment.
|
|
|
KEYWORD
|
|
|
Cancer therapy, Cell signalling, Epigenetics
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|